Alfred E Mann Institute for Biomedical Engineering at the Usc

“The board of directors has an executive committee that is comprised of the chairman of the board and two additional directors. The executive committee is responsible to the full board, is empowered to act for the full board as to authorities explicitly delegated to the executive committee by the board, and acts on behalf of the board in all executive decisions during periods between meetings of the full board.”

“The following individuals were employees at the university of southern california during fy23: carol l. Folt chrysostomos l. Nikias carolyn domen-broshears charles f. Zukoski michael quick james m. Staten yannis c. Yortsos dennis m. Foster jonathan g. Lasch, phd ishwar puri”

“Pursuant to the organization's bylaws, members have the right to not only elect directors but also to vote to (a) amend the bylaws or the certificate of incorporation, (b) enter into substantial loans on behalf of the corporation, (c) authorize a merger, consolidation or dissolution of the corporation, (d) authorize the transfer or lien of all or substantially all of the assets of the corporation, or (e) authorize any action that may adversely impact the corporation's status as a tax-exempt supporting organization.”

“Ami-usc's form 990 is reviewed at several levels. The organization engages an external public accounting firm to assist in the preparation and review of its form 990 and who signs as paid preparer. The review of form 990 is conducted prior to it being filed by management of the university of southern california.”

“Ami-usc maintains a conflict of interest policy for members of the board of directors. In general, the policy requires that a director must avoid using his or her position for personal gain or advantage, or to obtain a favored status for any special group, business, or family entity with which the director is affiliated. The policy applies to all voting members of the board of directors. A director will continue to be subject to the policy for five years after leaving the board. If a director becomes aware of a financial interest that may be material, he or she is required to disclose that financial interest to the members of the executive committee of the board of directors. Such disclosure is in addition to the required annual disclosures. The procedure that the executive committee and board of directors follow in reviewing a potential conflict of interest is consistent with the protocol described in the university of southern california's conflict of interest policy for members of the board of trustees.”

“Ami-usc follows the university of southern california's written document retention and whistleblower policies which were previously issued by university management and are currently in effect but not formally adopted by the ami-usc governing body.”

“The organization's governing documents are not available to the public. The organization follows the conflict of interest policy of the university of southern california which is made available on the university's website. The organization's financial statements are audited as part of a consolidated financial statement under the university of southern california which are available on the university's website.”

“The individuals reported as receiving compensation from a related organization in columns (e) and (f) in form 990, part vii are employees at the university of southern california, a tax-exempt related organization. Each of these individuals has devoted an average of 40-50 hours per week to their positions at the university of southern california.”

“The organization reimburses the university of southern california for use of its employees and other operating costs.”

“The alfred e. Mann institute at the university of southern california ("ami-usc") is a non-profit corporation engaged in biomedical research and development. The institute began with the vision of mr. Alfred e. Mann - chairman and ceo of minimed; chairman and founder of several other companies; and prominent entrepreneur in the field of biomedical technology - to establish a university-affiliated organization devoted to research, development, and commercialization of new biomedical technologies to improve human health and well-being. As a result of discussions between mr. Mann and former president steven b. Sample of the university of southern california, the institute was established and became affiliated with the university of southern california in 1998. Funding for the institute is provided through a gift of $112 million from alfred e. Mann and the alfred e. Mann foundation for biomedical research. The mission of ami-usc is to conduct innovative biomedical research and to foster the development and commercialization of biomedical devices and other biomedical technologies. Ami-usc collaborates with the usc faculty to identify, validate, develop, and transition to private industry new concepts for use in promoting public health. Its aim is to move promising new technology from the idea stage to successful commercialization in a short period of time. Ami-usc provides research opportunities for usc faculty and graduate students to support the usc goal of increasing knowledge for the public good. It also collaborates with noted clinicians and researchers at other institutions as appropriate. Ami-usc also supports a series of symposia in selected areas in which medical device technology has a strong established or potential role in the treatment of an economically important category of disorders. The organization dissolved as of november 15, 2022 and its assets were transferred to the university of southern california, a related, irc section 501(c)(3) organization.”

“Other changes in net assets or fund balances: transfer to usc ($239,129,903) other changes in net assets ($92,060) ---------------- total ($239,221,963)”